# Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

> **NCT00502463** · NA · COMPLETED · sponsor: **Austrian South Oncology Group** · enrollment: 51 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** 5-FU
- **RADIATION:** Radiotherapy
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00502463
- **Lead sponsor:** Austrian South Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-03
- **Primary completion:** 2010-01-19
- **Final completion:** 2014-01-19
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502463, "Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00502463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*